Zobowiązania Zmiana Data
AbbVie USD 43.1B 1.46B 2026-09
Agenus USD 231.82M 17.42M 2026-06
Amgen USD 23.23B 2.27B 2026-09
AstraZeneca USD 31.27B 286M 2026-09
Bristol-Myers Squibb USD 18.75B 94M 2026-09
Celldex Therapeutics USD 60.52M 808K 2026-09
CSL USD 4.61B 207M 2025-12
Eli Lilly USD 47B 745M 2026-09
Gilead Sciences USD 12B 982M 2026-09
GlaxoSmithKline GBP 20.72B 814M 2026-09
Glaxosmithkline GBP 20.72B 1.71B 2026-09
Incyte USD 1.44B 125.72M 2026-09
Intrexon USD 23.02M 38K 2024-06
J&J USD 55.46B 562M 2026-09
Jiangsu Hengrui CNY 6.9B 2.65B 2026-09
Karyopharm Therapeutics USD 117.3M 25.24M 2026-03
MacroGenics USD 108.82M 12.88M 2026-06
Merck EUR 8.12B 1.22B 2026-06
Merck USD 28.8B 1.07B 2026-09
Northwest Biotherapeutics USD 82.97M 4.93M 2026-03
Novartis USD 32.52B 777M 2026-09
Novavax USD 329.84M 729K 2026-09
Pfizer USD 31.73B 920M 2026-09
Regeneron Pharmaceuticals USD 6.2B 671.5M 2026-09
Rigel Pharmaceuticals USD 94.4M 7.76M 2025-09
Sangamo BioSciences USD 47.66M 1.9M 2025-06
Veracyte USD 84.21M 21.47M 2026-09